Loading...

Table of Content

    20 August 2026, Volume 41 Issue 8
    Network meta-analysis of the risk of urinary tract infection in patients with type 2 diabetes mellitus treated with different doses of SGLT-2 inhibitors
    Zhou Yu, Deng Liping, Hu Jun, Shou Yueying, Wu Meng, Gao Jieting, Li Wei
    2026, 41(8):  677-684.  doi:10.3969/j.issn.1004-583X.2026.08.001
    Asbtract ( 45 )   PDF (1350KB) ( 12 )   HTML ( 1)  
    Figures and Tables | References | Related Articles | Metrics

    Objective To evaluate the risk of urinary tract infection in patients with type 2 diabetes mellitus (T2DM) treated with five sodium-glucose cotransporter 2 (SGLT2) inhibitors using a network meta-analysis. Methods Chinese and English databases were searched for randomized controlled trials (RCTs) reporting urinary tract infection in patients with T2DM treated with empagliflozin, dapagliflozin, canagliflozin, henagliflozin, and ertugliflozin. The search period extended from database inception to February 28, 2026. After literature screening and data extraction, study quality was assessed using the Cochrane Handbook. Network meta-analysis was performed using RevMan 5.3 and Stata 15.1. Results A total of 20 RCTs involving 19 intervention regimens were included. The network meta-analysis showed that 15 mg ertugliflozin was associated with a lower risk of urinary tract infection than placebo; the risk of urinary tract infection with 15 mg ertugliflozin was also lower than that with 100 mg canagliflozin, 5 mg dapagliflozin, 10 mg empagliflozin, 10 mg dapagliflozin, and 300 mg canagliflozin. The risk of urinary tract infection with 5 mg ertugliflozin was lower than that with 300 mg canagliflozin. No significant differences were found among the other interventions. The ranking results indicated that the risk of urinary tract infection, from low to high, was as follows: 25 mg ertugliflozin <15 mg ertugliflozin <5 mg henagliflozin <10 mg henagliflozin <5 mg ertugliflozin <1 mg ertugliflozin <1 mg empagliflozin <1 mg dapagliflozin < placebo <2.5 mg dapagliflozin <25 mg empagliflozin <50 mg empagliflozin <5 mg empagliflozin <100 mg canagliflozin <5 mg dapagliflozin <10 mg empagliflozin <10 mg ertugliflozin <10 mg dapagliflozin <300 mg canagliflozin. Publication bias analysis suggested a low likelihood of publication bias in this study. Conclusion In terms of reducing the clinical incidence of urinary tract infection, 25 mg ertugliflozin, 15 mg ertugliflozin, and 5 mg henagliflozin demonstrated relatively higher safety.

    Value of ST segment elevation in lead aVR and QRS duration on electrocardiogram for assessing the risk of cardiogenic shock in patients with acute anterior myocardial infarction
    Zhou Lili, Yan Xia, Yan Jin
    2026, 41(8):  685-689.  doi:10.3969/j.issn.1004-583X.2026.08.002
    Asbtract ( 24 )   PDF (910KB) ( 6 )   HTML ( 1)  
    Figures and Tables | References | Related Articles | Metrics

    Objective To investigate the value of ST segment elevation in lead aVR and QRS duration on electrocardiogram for assessing the risk of cardiogenic shock (CS) in patients with acute anterior myocardial infarction (AAMI).Methods A total of 178 patients with AAMI admitted to our hospital from October 2022 to October 2025 were retrospectively enrolled. According to the occurrence of CS, patients were divided into a CS group (46 cases) and a non-CS group (132 cases). Clinical data were compared between the two groups. Univariate and multivariate logistic regression analyses were used to evaluate the risk of CS in patients with AAMI. Results The proportions of patients with Killip class ≥ III and left ventricular ejection fraction (LVEF) <50% were significantly higher in the CS group than in the non-CS group, and the magnitude of ST segment elevation in lead aVR and QRS duration were also greater in the CS group (P<0.05). Multivariate logistic regression analysis showed that Killip class, LVEF <50%, ST segment elevation in lead aVR, and QRS duration were risk factors for cardiogenic shock in patients with AAMI (P<0.05). Receiver operating characteristic (ROC) curve analysis showed that the areas under the curve for ST segment elevation in lead aVR and QRS duration alone, as well as in combination, in predicting cardiogenic shock in patients with AAMI were 0.812, 0.785, and 0.935, respectively; the corresponding sensitivities were 0.761, 0.739, and 0.848, and the specificities were 0.758, 0.765, and 0.886. Conclusion ST segment elevation in lead aVR and prolonged QRS duration on electrocardiogram are independent risk factors for cardiogenic shock in patients with AAMI. Combined detection of these two indicators may serve as an auxiliary marker for early identification of CS risk in patients with AAMI, thereby facilitating the identification and intervention of high-risk patients in clinical practice.

    Construction and evaluation of a hierarchical management model for chronic obstructive pulmonary disease in primary hospitals: A multicenter study
    Yao Yu, Ye Aiqiu, Feng Jian, Li Xiachuan, Ding Yuehong, You Zhenhua, Huang Jinhong, Chen Liangyun
    2026, 41(8):  690-694.  doi:10.3969/j.issn.1004-583X.2026.08.003
    Asbtract ( 27 )   PDF (866KB) ( 27 )   HTML ( 1)  
    Figures and Tables | References | Related Articles | Metrics

    Objective To construct a hierarchical management model for chronic obstructive pulmonary disease (COPD) suitable for primary hospitals and to evaluate its effects on the risk of acute exacerbation, lung function, and quality of life in patients. Methods A total of 120 patients with stable COPD diagnosed in 3 primary hospitals between January 2023 and January 2025 were enrolled and assigned to a control group (routine management) and an intervention group (hierarchical management). After 12 months of follow-up, the annual number of acute exacerbations, pulmonary function indices, and COPD Assessment Test (CAT) scores were compared between the two groups. Results A total of 112 patients completed the follow-up, including 57 in the intervention group and 55 in the control group. After 12 months of intervention, the annual number of acute exacerbations was significantly lower in the intervention group than in the control group (2[1, 2] vs 2[2, 3], P=0.016). The percentage of predicted forced expiratory volume in the first second (FEV1%) was significantly improved in the intervention group compared with the control group (64[63, 66]% vs 61[58, 63]%, P=0.001). The reduction in CAT score was also significantly greater in the intervention group than in the control group (9[8, 10] vs 12[9, 14], P=0.001).Conclusion Implementation of a hierarchical management model for COPD in primary hospitals can effectively improve clinical outcomes and has potential for broader application.

    Effect of mechanical insufflation-exsufflation technique on the prevention and treatment of pulmonary infection in ICU patients with weak or absent cough reflex
    Chen Zhi, Ding Pengyan, Hao Guizhen, Li Yulong, Niu Shiliang, Shen Limin, Liu Chunxia
    2026, 41(8):  695-699.  doi:10.3969/j.issn.1004-583X.2026.08.004
    Asbtract ( 32 )   PDF (419KB) ( 60 )   HTML ( 2)  
    Figures and Tables | References | Related Articles | Metrics

    Objective To investigate the efficacy of the mechanical insufflation-exsufflation (MI-E) in preventing and treating pulmonary infection in intubated or tracheostomized ICU patients with weak or absent cough reflex. Methods A randomized controlled trial was conducted in 115 intubated or tracheostomized patients with weak or absent cough reflex admitted to the ICU of Hebei General Hospital from January 2022 to December 2023, including 57 patients in the observation group and 58 in the control group. The control group received conventional airway clearance measures, such as chest percussion and sputum expectoration, postural drainage, nebulization, induced coughing, and suctioning. The observation group received airway clearance using the MI-E to simulate physiological coughing. The two groups were compared in terms of percutaneous oxygen saturation (SpO2), blood gas parameters, incidence of pulmonary infection, pulmonary infection control rate, Clinical Pulmonary Infection Score (CPIS), ICU length of stay (days), and total hospital stay (days). Results After treatment, the observation group had better SpO2 and blood gas parameters than the control group: SpO2 (95.84±1.77)% vs (92.84±1.23)%, arterial partial pressure of oxygen (PaO2) (82.45±2.91) mmHg vs (70.89±2.06) mmHg, arterial partial pressure of carbon dioxide (PaCO2) (37.29±0.88) mmHg vs (41.10±1.06) mmHg, alveolar-arterial oxygen difference (A-aDO2) (28.32±3.03) mmHg vs (35.55±2.46) mmHg, and oxygenation index (301.65±9.21) mmHg vs (280.98±4.90) mmHg. The incidence of pulmonary infection in the observation group was 3.5% (2/57), lower than 15.5% (9/58) in the control group (P<0.05); the pulmonary infection control rate in the observation group was 38.6% (22/57), higher than 20.7% (12/58) in the control group (P<0.05). The CPIS score in the observation group was (5.53±1.12), lower than that in the control group (6.48±0.10) (P<0.05). The length of ICU stay in the observation group was (7.41±0.67) d, shorter than that in the control group (10.06±0.98) d (P<0.05). There was no statistically significant difference in total length of hospital stay between the two groups (P>0.05). Conclusion Applying the MI-E for airway management in intubated or tracheostomized ICU patients with weak or absent cough reflex can significantly reduce sputum retention, improve blood gas parameters such as the oxygenation index, control pulmonary infection, and shorten ICU stay. The technique is feasible, safe, and worthy of wider clinical application.

    Predictive value of NLR combined with serum LDL-C/HDL-C, Lp-PLA2, and D-dimer for early neurological deterioration in patients with cerebral infarction
    Zhang Shujing, Liu Yang, Zhou Zhiming, Lu Guojie
    2026, 41(8):  700-704.  doi:10.3969/j.issn.1004-583X.2026.08.005
    Asbtract ( 24 )   PDF (919KB) ( 41 )   HTML ( 1)  
    Figures and Tables | References | Related Articles | Metrics

    Objective To investigate the predictive value of the neutrophil-to-lymphocyte ratio (NLR), low-density lipoprotein cholesterol (LDL-C)/high-density lipoprotein cholesterol (HDL-C), lipoprotein-associated phospholipase A2 (Lp-PLA2), and D-dimer (D-D) for early neurological deterioration (END) in patients with cerebral infarction (CI). Methods The clinical data of 302 patients with CI admitted to our hospital from December 2022 to December 2025 were retrospectively analyzed. According to the National Institutes of Health Stroke Scale (NIHSS) score, the patients were divided into a deterioration group (n=81) and a favorable group (n=221). General clinical data and laboratory indicators were compared between the two groups. Independent predictors of END in patients with CI were identified, the relationships between NLR, LDL-C/HDL-C, Lp-PLA2, D-D, and neurological function were analyzed, and the predictive value of NLR, LDL-C/HDL-C, Lp-PLA2, and D-D for END was explored. Results Multivariate Logistic regression analysis showed that higher LDL-C/HDL-C, Lp-PLA2, D-D, NLR, and NIHSS score were all independent predictors of END in patients with CI (P<0.05). Each of these laboratory indicators could effectively predict END, and the combined predictive value of the four markers was superior (P<0.05). Conclusion NLR, LDL-C/HDL-C, Lp-PLA2, and D-D are closely associated with END in patients with CI, and their combined application may assist clinical prediction.

    Association between right-to-left shunt and the severity of white matter lesions
    Guo Yiming, Zhao Haina, Chen Danni, Chen Beilei, Li Xiaobo, Jiang Chao
    2026, 41(8):  705-710.  doi:10.3969/j.issn.1004-583X.2026.08.006
    Asbtract ( 20 )   PDF (529KB) ( 4 )   HTML ( 1)  
    Figures and Tables | References | Related Articles | Metrics

    Objective To investigate the association between right-to-left shunt (RLS) and the severity of white matter lesions (WML). Methods Patients hospitalized in the Department of Neurology of Northern Jiangsu People’s Hospital from January 2022 to July 2025 who underwent contrast-enhanced transcranial doppler were consecutively enrolled. Baseline information and clinical characteristics were collected. All enrolled patients underwent contrast-enhanced transcranial doppler and brain magnetic resonance imaging. WML was defined as hyperintense signals on T2-weighted and fluid-attenuated inversion recovery (FLAIR) images in the periventricular or deep white matter regions. WML severity was assessed using the Fazekas scale. Mild WML was defined as 0-3 points, and severe WML as 4-6 points. RLS was defined as the presence of at least one microembolic signal in the unilateral middle cerebral artery monitored under the single-channel double-depth mode during contrast-enhanced transcranial doppler. Results A total of 125 hospitalized patients who completed contrast-enhanced transcranial doppler were included, including 93 patients in the mild WML group (74.4%) and 32 patients in the severe WML group (25.6%). RLS was positive in 32 patients (25.6%). Univariate analysis using the Mann-Whitney U test showed that, compared with the mild WML group, the severe WML group had a higher proportion of RLS-positive patients (P<0.01), significantly higher neutrophil count (P=0.003), and significantly higher neutrophil-to-lymphocyte ratio (NLR)(P=0.004). The Mini-Mental State Examination score was significantly lower in the severe WML group (P<0.01). Binary logistic regression with RLS positivity, NLR, age, hypertension, and diabetes as independent variables showed that RLS positivity (OR=39.290, 95%CI: 9.54-161.74, P<0.01), age (OR=1.090, 95%CI: 1.02-1.16, P=0.011), and hypertension (OR=3.749, 95%CI: 1.02-13.84, P=0.047) were independent risk factors for WML severity. Single-factor ROC curve analysis showed that the area under the curve (AUC) of RLS positivity for predicting WML severity was 0.76 (95%CI: 0.663-0.875, P<0.01), indicating good predictive performance, whereas age (AUC=0.557) and hypertension (AUC=0.528) showed relatively poor independent predictive performance. A combined predictive model was constructed by incorporating RLS positivity, age, and hypertension into binary logistic regression, and an ROC curve was generated based on the predicted probability. The results showed an AUC of 0.831(95%CI: 0.743-0.920, P<0.01), with an optimal cutoff value of 0.431, sensitivity of 0.656, and specificity of 0.946, suggesting that the multi-indicator combined model has good predictive value for WML severity.Conclusion The severity of WML may be associated with the presence of RLS.

    Clinical value of cerebrospinal fluid and serum immunoglobulins in the differential diagnosis of anti-NMDAR encephalitis and anti-LGI1 antibody-associated encephalitis
    Zheng Xinwei
    2026, 41(8):  711-715.  doi:10.3969/j.issn.1004-583X.2026.08.007
    Asbtract ( 26 )   PDF (872KB) ( 30 )   HTML ( 1)  
    Figures and Tables | References | Related Articles | Metrics

    Objective To analyze the characteristics of cerebrospinal fluid (CSF) and serum immunoglobulins in patients with anti-N-methyl-D-aspartic acid receptor (NMDAR) encephalitis and anti-leucine-rich glioma inactivated protein 1 (LGI1) antibody-associated encephalitis, as well as the correlations between CSF and serum immunoglobulins in each group, and to explore their clinical value. Methods A total of 30 patients with anti-NMDAR encephalitis (anti-NMDAR encephalitis group) and 21 patients with anti-LGI1 antibody-associated encephalitis (anti-LGI1 antibody-associated encephalitis group) admitted to Tianjin Huanhu Hospital from January 2019 to January 2024 were selected. The concentrations of immunoglobulin G (IgG), immunoglobulin A (IgA), and immunoglobulin M (IgM) in CSF, as well as serum immunoglobulins (IgG, IgA, and IgM), were measured. CSF and serum immunoglobulin levels were compared between the two groups, and the correlations between CSF and serum immunoglobulins were analyzed in each group. Results There were no statistically significant differences in CSF or serum IgG and IgA between the anti-NMDAR encephalitis group and the anti-LGI1 antibody-associated encephalitis group (P>0.05). However, both CSF and serum IgM levels were significantly higher in the anti-NMDAR encephalitis group than in the anti-LGI1 antibody-associated encephalitis group (P<0.05). In the anti-NMDAR encephalitis group, CSF IgA was positively correlated with serum IgA (P<0.05), and CSF IgM was positively correlated with serum IgM (P<0.05). In the anti-LGI1 antibody-associated encephalitis group, CSF IgG was positively correlated with serum IgG (P<0.05), and CSF IgA was positively correlated with serum IgA (P<0.05).Conclusion CSF and serum immunoglobulin levels may provide an auxiliary reference for the clinical differentiation of anti-NMDAR encephalitis and anti-LGI1 antibody-associated encephalitis. Differences in the correlations between CSF and serum immunoglobulins in the two groups suggest possible heterogeneity in blood-brain barrier disruption and may involve different pathophysiological mechanisms.

    Analysis of factors associated with cognitive impairment in patients with stage 5 chronic kidney disease undergoing hemodialysis and development of a risk prediction model
    Song Xufang, Chen Feifei, Wang Linfeng
    2026, 41(8):  716-724.  doi:10.3969/j.issn.1004-583X.2026.08.008
    Asbtract ( 20 )   PDF (1632KB) ( 11 )   HTML ( 1)  
    Figures and Tables | References | Related Articles | Metrics

    Objective To investigate the factors associated with cognitive impairment (CI) in patients with stage 5 chronic kidney disease undergoing hemodialysis and to develop a risk prediction model. Methods A total of 184 patients with stage 5 chronic kidney disease undergoing hemodialysis, who were treated in the Department of Nephrology, Rheumatology, and Immunology of the First People's Hospital of Pingdingshan City from November 2022 to November 2025, were enrolled and randomly assigned in a 6∶2∶2 ratio to a modeling set (training set: 110 cases; test set: 37 cases) and an internal validation set (37 cases). Based on CI screening results, patients were divided into the CI group and the no-CI group. Univariate analysis, LASSO regression, and multivariate logistic regression were used to identify factors associated with CI, and a prediction model was developed. The predictive performance of the model was further validated using the test set. Results Among the 184 patients, 60 developed CI, with an overall incidence of 32.61%. After LASSO regression screening of 26 variables, multivariate logistic regression identified age (OR=1.074), years of education (OR=0.808), duration of dialysis (OR=1.074), serum albumin (OR=0.856), and use of beta-blockers (OR=4.359) as independent factors associated with CI (all P<0.05). The area under the curve (AUC) of the prediction model was 0.922 in the training set (95%CI: 0.866-0.978), 0.943 in the validation set (95%CI: 0.814-0.993), and 0.933 in the test set (95%CI: 0.800-0.989). The mean AUC of the model was 0.909 (95%CI: 0.814-0.993) on 5-fold cross-validation. The calibration curve showed high agreement between predicted and observed probabilities (P>0.05). According to the decision curve analysis, when the threshold probability ranged from 0.080 to 0.320, using this model for decision-making provided additional clinical net benefit. Conclusion The incidence of CI is relatively high in patients with stage 5 chronic kidney disease undergoing hemodialysis. Older age, longer duration of dialysis, and beta-blocker use are independent risk factors, whereas longer years of education and higher serum albumin levels are protective factors. The developed prediction model demonstrates good discrimination, calibration, and clinical utility, and may serve as a tool for early identification of patients at high risk of CI.

    Immune checkpoint inhibitor-associated fulminant myocarditis complicated by myositis: A case report and literature review
    Ma Liyun, Ren Xiyan, Yan Chunliang
    2026, 41(8):  725-730.  doi:10.3969/j.issn.1004-583X.2026.08.009
    Asbtract ( 27 )   PDF (1594KB) ( 4 )   HTML ( 1)  
    Figures and Tables | References | Related Articles | Metrics

    Objective To investigate the clinical characteristics of immune checkpoint inhibitor-associated myocarditis complicated by myositis, improve clinicians’ awareness of this condition, and reduce the rates of misdiagnosis and missed diagnosis. Methods The clinical data of one patient with immune checkpoint inhibitor-associated myocarditis complicated by myositis were retrospectively analyzed, and the relevant literature was reviewed. Results The patient was a 64-year-old man diagnosed with stage ⅢB squamous cell carcinoma of the right lung. After one cycle of tislelizumab combined with chemotherapy, on day 31, he developed acute fulminant myocarditis complicated by myositis, manifested by marked elevation of cardiac enzymes (peak troponin Ⅰ, 3.398 μg/L), third-degree atrioventricular block, and type Ⅱ respiratory failure. Following comprehensive treatment with high-dose methylprednisolone pulse therapy (1 g/d×3 d) combined with intravenous immunoglobulin (20 g/d×5 d), temporary cardiac pacing, and noninvasive ventilatory support, the patient gradually improved. As of February 2026, no recurrence of myocarditis or myositis had been observed, and tumor control remained stable. Conclusion Immune checkpoint inhibitor-associated myocarditis complicated by myositis is a rare and life-threatening complication of immunotherapy, characterized by rapid progression and high mortality. Early recognition and diagnosis, together with timely and potent immunomodulatory therapy, are critical for saving lives and improving outcomes.

    A case report of BRAF-related RASopathies and literature review
    Lu Liju, Wei Xuemei, He Xiaoyin, Li Juan, Li Xiuzhen, Lu Cailing
    2026, 41(8):  731-735.  doi:10.3969/j.issn.1004-583X.2026.08.010
    Asbtract ( 24 )   PDF (977KB) ( 2 )   HTML ( 2)  
    Figures and Tables | References | Related Articles | Metrics

    Objective To investigate the association between BRAF (v-raf murine sarcoma viral oncogene homolog B) gene variant sites and the clinical phenotypes of RASopathies, and to improve understanding, diagnosis, and management of this disease. Methods A retrospective analysis was performed of the clinical data of a child with a BRAF (p.Asp638Glu) gene variant who was treated at Maternity and Child Health Care of Guangxi Zhuang Autonomous Region. CNKI, Wanfang Data, Google Scholar, and PubMed were searched to collect reported cases with the same variant site, and their clinical phenotypes were compared and analyzed. Results The child in this case mainly presented with feeding difficulties after birth, growth and developmental delay, diarrhea, recurrent respiratory tract infections, and febrile seizures. Genetic testing revealed a heterozygous BRAF c.1914T>G (p.Asp638Glu) variant. The literature search identified 13 reported cases with the BRAF (p.Asp638Glu) variant, and phenotype comparison was conducted across 14 cases in total. The following phenotypes were confirmed: developmental delay, 13/14; abnormal brain structures on cranlar MRI, 11/14; epilepsy, 9/14; feeding difficulties, 9/14; short stature, 9/14; distinctive facial features, 8/14; skin and hair abnormalities, 8/14; and cardiac abnormalities, 3/14.Conclusion RASopathies associated with the BRAF (p.Asp638Glu) variant are characterized by multisystem involvement, with frequent impairment of the nervous, digestive, and skin systems. The phenotype shows overlap and heterogeneity, and no clear genotype-phenotype correlation has yet been identified. Early genetic testing is recommended for clinically suspected cases to confirm the diagnosis.

    Risk factors for comorbid anxiety and depression and for a single emotional disorder in patients with lung cancer receiving chemoradiotherapy
    Chen Huimin, Ding Ruijuan, Liu He
    2026, 41(8):  736-741.  doi:10.3969/j.issn.1004-583X.2026.08.011
    Asbtract ( 21 )   PDF (858KB) ( 115 )   HTML ( 1)  
    Figures and Tables | References | Related Articles | Metrics

    Objective To analyze the risk factors for comorbid anxiety and depression and for a single emotional disorder in patients with lung cancer receiving chemoradiotherapy.Methods A total of 108 patients with lung cancer who underwent chemoradiotherapy at Luohe Central Hospital from September 2022 to September 2025 were enrolled. Sociodemographic data, clinical characteristics, treatment-related factors, and psychological and social factors were collected. Anxiety and depression were assessed 2 weeks after chemoradiotherapy. Patients with both anxiety and depression symptoms were assigned to the comorbidity group (n=42), those with only one emotional symptom were assigned to the single-symptom group (n=40), and the remaining patients were assigned to the asymptomatic group (n=26). Multinomial logistic regression was used to identify independent risk factors for emotional disorders.Results There were 42 patients with comorbid anxiety and depression, 40 patients with either anxiety or depression alone, and 26 asymptomatic patients. Significant differences were observed among the three groups in educational level, personal monthly income, clinical stage, perceived social support scale (PSSS) score, adverse reaction grade, and Pittsburgh sleep quality index (PSQI) score (P<0.05). Logistic regression analysis showed that personal monthly income <3 000 yuan, clinical stage Ⅲ-Ⅳ, PSSS score <40, and PSQI score >7 were independent risk factors for single emotional disorder in patients with lung cancer receiving chemoradiotherapy (P<0.05). Personal monthly income <3 000 yuan, clinical stage Ⅲ-Ⅳ, PSSS score <40, adverse reaction grade 3-4, and PSQI score >7 were independent risk factors for comorbid anxiety and depression (P<0.05). Conclusion Lower personal monthly income, advanced clinical stage, low social support, more severe adverse reactions, and sleep disturbance are risk factors for comorbid anxiety and depression in patients with lung cancer receiving chemoradiotherapy. Early identification of high-risk patients and comprehensive interventions are needed to improve both physical and mental health.